Gut Bacteria, Metabolic Syndrome, Personalized Nutrition
Conditions
Keywords
Metabolic syndrome, Gut microbiota, Personalized dietary advice, Food literacy
Brief summary
FLORA is a longitudinal intervention study with a randomized, parallel group design. Primary objective is to improve metabolic health through gut microbiota modulation by means of a retailer-driven personalized dietary intervention in a real-life setting. Four hundred Flemish pre-metabolic adults will be randomly divided into a control and treatment arm, each comprising 200 participants. The study period is divided into three phases: a four weeks characterization, a twelve weeks intervention, and a four weeks post-intervention phase. During the intervention phase, control participants' online Collect&Go shopping carts are adjusted in accordance with Flemish food-based dietary guidelines. Based on the same guidelines, participants are provided with personalized dietary advice considering their usual dietary pattern and level of food literacy. In the treatment arm, a similar intervention will be applied using guidelines based on a microbiota modulation diet (MMD). During intervention, all participants can contact a dietician helpline for additional advice on study-related dietary issues. Over the five months, saliva and fecal samples will be collected on a regular basis, with an intensive sampling period of seven consecutive days at the end of each study phase. A GP consult consisting of a short medical exam, blood withdrawal and medical questionnaire takes place each month. Further, online questionnaires on lifestyle, health and well-being will be sent by e-mail and each five days, participants complete a food diary through their smartphone. Fecal, saliva, blood samples and meta-data will be analysed to detect changes in metabolic health.
Interventions
OTHERMicrobiota modulation diet
The Collect&Go shopping carts of the 400 participants will be adapted by replacing food products by healthier alternative ones based on the Flemish food-based dietary guidelines and the microbiota modulation diet guidelines for the control and study arm respectively. Based on these guidelines, and the habitual dietary pattern and level of food literacy of the participant, personalized dietary advice will be provided. A dietitian helpline will be available for further nutritional issues as well.
Sponsors
Vlaams Instituut voor Biotechnologie
KU Leuven
SmartWithFood
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes
Inclusion criteria
* Willingness to participate to the study and to sign the informed consent (Dutch) * Older than 18 years * Diagnosed with pre-metabolic syndrome (diagnosed with central obesity \[waist circumference ≥80 cm for women and ≥94 cm for men\] and one of the following criteria: elevated blood pressure \[systolic ≥130 mm Hg, diastolic ≥85 mm Hg\], raised triglycerides \[\>150 mg/dL\], reduced HDL-cholesterol \[\<40 mg/dL in men, \<50 mg/dL in women\], or raised fasting plasma glucose \[≥100 mg/dL\] * Residing in Belgium, no travels abroad planned longer than seven consecutive days during the five-months study period * Willingness to follow dietary guidelines during the three-months intervention period * Willingness to purchase bulk groceries primarily at Colruyt Group using the Collect&Go platform during the five-months study period * Access to a -20-18°C freezer
Exclusion criteria
* Chronic constipation (less than one defecation once a week) * Gastro-intestinal surgery within the past 3 months * Inflammatory bowel disease (IBD) or diverticulitis * Irritable bowel syndrome (IBS) * Any food allergy or food intolerance * Metabolic syndrome * Diabetes Mellitus Type 1 or Type 2 * Coeliac disease * Pregnant women or women planning a pregnancy during the study period * Lactating women * Subjects on a specific diet (e.g. vegetarian/vegan diet, gluten-free diet, lactose-free diet, high-protein diet) * Subjects being treated for hypertension or high cholesterol
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Reduced serum triglycerides | 5 months | Participants' serum triglyceride level (mg/dL) decreases during the study period (blood sample analysis) |
| Reduced waist circumference | 5 months | Participants' waist circumference (cm) decreases during the study period |
| Reduced blood pressure | 5 months | Participants' blood pressure (mm Hg) decreases during the study period |
| Elevated HDL-cholesterol | 5 months | Participants' HDL-cholesterol levels (mg/dL) increase during the study period (blood sample analysis) |
| Reduced fasting plasma glucose | 5 months | Participants' fasting plasma glucose levels decrease during the study period (blood sample analysis) |
Outcome results
None listed